HORIZON THERAPEUTICS PLC - COMMON STOCK-FO (HZNP)

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / COMMON STOCK-FO
Total 13F shares
200,083,220
Share change
+11,597,797
Total reported value
$15,547,804,340
Put/Call ratio
103%
Price per share
$77.68
Number of holders
426
Value change
+$939,522,566
Number of buys
258
Number of sells
177

Institutional Holders of HORIZON THERAPEUTICS PLC - COMMON STOCK-FO (HZNP) as of Q3 2020

As of 30 Sep 2020, HORIZON THERAPEUTICS PLC - COMMON STOCK-FO (HZNP) was held by 426 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 200,083,220 shares. The largest 10 holders included VANGUARD GROUP INC, FMR LLC, BlackRock Inc., JANUS HENDERSON GROUP PLC, RENAISSANCE TECHNOLOGIES LLC, Avoro Capital Advisors LLC, PAULSON & CO. INC., WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, JPMORGAN CHASE & CO, and Voya Investment Management LLC. This page lists 426 institutional shareholders reporting positions in this security for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.